Company intelligence / Profile preview

Company 3

Ownership: Private
Development stage: Other

Overview

3Biotech is an independent drug development-focused biotech company based in Paris, France. It specializes in Chemistry Manufacturing and Control (CMC) strategy and execution for pharmaceutical and biotech partners. The firm has supported over ninety projects with molecules advancing through clinical phases up to Phase 3. Its expertise lies in ensuring safety, efficacy, and manufacturability of investigational drugs as they progress toward first-in-human studies or later-stage trials.

Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

Collaborates with pharmaceutical industry partners and healthcare investment sector entities including incubators/business accelerators.

Beyond the preview

Go deeper on Company 3.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Company 3.

Explore the full profile